Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lexicon Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LXRX.
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Innate Pharma (NASDAQ:IPHA), Voyager Therapeutics (NASDAQ:VYGR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and Eledon Pharmaceuticals (NASDAQ:ELDN).
Lexicon Pharmaceuticals has a consensus price target of $4.50.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $0.5095 last updated April 17, 2025 at 4:11 PM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.